Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)
Clinical trial NCT05085990 · COMPLETED
Trial details
- NCT number
- NCT05085990
- Sponsor
- Protara Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-08
- Primary completion
- 2024-09-12
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.